Kim, W
Jones, J O
Diamond, M
Haqq, C
Molina, A
Small, E J
Ryan, C J
Article History
Received: 23 March 2014
Revised: 27 May 2014
Accepted: 28 May 2014
First Online: 22 July 2014
Competing interests
: AM is an employee of Johnson & Johnson and holds stock ownership. CH is a former employee of Johnson & Johnson and holds stock ownership. CJR has received honoraria from Janssen. JM is a member of the NCCN's Prostate Cancer Early Detection Panel and, on behalf of the NCCN, has received honoraria only for lectures (usually annual meeting for guidelines update and occasional CME activity) or other activities (panel participation for guidelines adaptation for other countries); has received an honorarium from the Genomic Health Scientific Advisory Board (related activity: presentation (no honorarium), collaboration with the North Carolina-Louisiana Prostate Cancer Project (no funded effort or honorarium)); is a cofounder and chief medical officer of AndroBioSys, with ownership interest (value: none); is associated with Medivation MTA for MDV3100 (no research support or honoraria); is a consultant to and collaborator on research at New York University School of Medicine; and was an initial investor (value: none) in and an advisory board member for Simulated Surgical Systems. The remaining authors declare no conflict of interest.